It does seem ironic that the industry most responsible for the creation and continuation of our current opioid epidemic could also be the main beneficiary of this next wave of treatment funding.
“…over the past five years, less than 10% of the nearly $40 billion in tobacco payments went towards such efforts.”
I’d feel better if I knew some in our brilliant science community were working hard on ways to taper patients, if just the most highly motivated, off the medications with a reduced risk of return to heroin.
The real solution would have been for Prince to have received treatment for his drug problem, which by this time was a far bigger issue than his somatic pain.
The theory is that the more users we put in jail or prison, the fewer left out on the street. So why hasn’t that substantially reduced arrest and overdose statistics?
I’ve been expecting a public relations counterattack on behalf of, and probably funded by, the pharmaceutical industry.
Based on the vast number of prescriptions for opioid medications written by US practitioners over the past few decades, we’ve become the clear leaders in opioid prescribing.
Many of those programs treat opioid users without relying on medication, and yet manage to achieve remarkable success rates– sometimes 80% over a five year period.